Similar articles

• [Treatment of Parkinson's disease with L-dopa. 77 cases].

  Boudin G, Castaigne P, Lhermitte F, Beck H, Guillard A, Marteau R, Pepin B, Rondot P, Raphy B. Boudin G, et al. Rev Neurol (Paris). 1970 Feb;122(2):89-102. Rev Neurol (Paris). 1970. PMID: 4931719 Clinical Trial. French. No abstract available.
• Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.

  Muenter MD. Muenter MD. Neurology. 1970 Dec;20(12):6-13. Neurology. 1970. PMID: 4924343 Clinical Trial. No abstract available.
• [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].

  Ferel D. Ferel D. Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94. Schweiz Med Wochenschr. 1972. PMID: 4551909 Clinical Trial. German. No abstract available.
• Therapeutic uses and side effects of L-dopa.

  Boshes B. Boshes B. Adv Intern Med. 1972;18:219-49. Adv Intern Med. 1972. PMID: 4576081 Review. No abstract available.
• L-dopa therapy in Parkinson's disease.

  Lipman IJ. Lipman IJ. Va Med Mon (1918). 1971 May;98(5):242-8. Va Med Mon (1918). 1971. PMID: 4931138 Review. No abstract available.